Posttest for Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities

The primary role of the FDA is to:*
- A. Protect the consumer
- B. Assess a therapy's marketing potential
- C. Conduct translational studies of emerging therapies
- D. Determine the safety of medical treatment
The Orphan Disease Act provides incentives to biopharmaceuticals developing therapies for rare diseases. These include:*
- A. Tax credits
- B. Marketing exclusivity
- C. Grant funding
- D. All of the above
Which of the following statements about clinical trials is NOT true?*
- A. Clinical trials are research studies in humans
- B. Safety is monitored throughout a clinical trial
- C. About 40 percent of therapies in clinical trials will ultimately receive marketing approval
- D. Clinical trial participants are usually compensated for travel and accommodations
The clinical trial Phase that enrolls the most patients is:*
- A. Phase 1
- B. Phase 1/2
- C. Phase 2
- D. Phase 3
Which of the following statements about Phase 3 trials is NOT true?*
- A. Phase 3 trials are known as pivotal studies
- B. Phase 3 trials are usually multicenter studies
- C. Phase 3 trials cost about the same as Phase 1/2 studies
- D. Phase 3 trials evaluate how a medication works in comparison to existing treatments
Equipment used in clinical trials for inherited retinal diseases includes:*
- A. Electroretinograms
- B. Micro-perimeters
- C. Mobility courses
- D. All of the above
Which of the following is NOT true?*
- A. FFB’s clinical consortium has a site in Brazil
- B. FFB’s clinical consortium is no longer adding sites
- C. FFB’s clinical consortium conducts natural history studies
- D. FFB’s clinical consortium’s mission is to accelerate the development of treatments for IRDs
The My Retina Tracker Genetic Testing Program provides all of the following except:*
- A. No-cost genetic testing
- B. No-cost genetic counseling
- C. No-cost clinical exams
- D. No-cost patient registry
The leading reason patients enroll in clinical trials is to:*
- A. Get free medical care
- B. Advance medical research
- C. Earn extra money
- D. Play a more active role in their own health care
Dozens of treatment clinical trials are underway for people with inherited retinal diseases. Which of the following approaches are the most clinical trials underway for?*
- A. Stem cells
- B. Small molecules
- C. Gene therapies
- D. Medical devices

Posttest for Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities

Step 1 of 2

Join our newsletter